PharmaSmart International Inc. designs, manufactures, and distributes innovative blood pressure screening systems to assist in the detection and management of hypertension. For over 20 years PharmaSmart has served its customers while continuously advancing research and development of its clinically validated Class II–Non-Invasive products. PharmaSmart’s existing network of blood pressure machines successfully administers more than 65 million blood pressure tests annually.
PharmaSmart blood pressure screening system technology and patented cuff design has been clinically evaluated for compliance with The Association for the Advancement of Medical Instrumentation’s standard (AAMI) and to a modified British Hypertension Society (BHS) Protocol. The clinical study was performed at the University of Tennessee, and the results were published in the technical research journal Blood Pressure Monitoring (vol 9, no 1). The study concluded: “The PharmaSmart PS-2000 met the AAMI requirements for accuracy. Most notably, the mean difference between well-trained clinicians and the device readings were very small (0.07 systolic and –0.3 diastolic).
Further, when analyzed in accordance to the BHS evaluation protocol, the PS-2000 achieved the highest grade–an ‘A.’ It is well suited for its role as a high volume, self-administered BP screening device.
Notified Body/ Registrar / Certification Body
PharmaSmart International, Inc. maintains ISO 13485:2016 and MDSAP certification and is audited every year by Intertek.